Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Nov-18 4:10 PM View:  | Haemonetics Corp. (HAE) | 08-Nov-18 | Market Sale | 12,322 | $114.50 | $1,410,870.00 | (45%) 27.66K to 15.34K | 23% |
| 19-Sep-18 5:00 PM View: | Haemonetics Corp. (HAE) | 17-Sep-18 | Option Exercise | 25,122 | $38.39 | $964,363.00 | 75% 33.36K to 58.48K | |
| 19-Sep-18 5:00 PM View: | Haemonetics Corp. (HAE) | 17-Sep-18 | Market Option Sale (Planned) | 25,122 | $111.82 | $2,809,280.00 | (43%) 58.48K to 33.36K | 21% |
| 19-Sep-18 5:00 PM View: | Haemonetics Corp. (HAE) | 17-Sep-18 | Market Sale (Planned) | 5,702 | $111.82 | $637,629.00 | (17%) 33.36K to 27.66K | 21% |
| 30-Jul-18 6:16 PM View: | Haemonetics Corp. (HAE) | 26-Jul-18 | Grant | 1,696 | -- | -- | 5% 31.66K to 33.36K | |
| 04-Dec-17 4:14 PM View: | Haemonetics Corp. (HAE) | 01-Dec-17 | Option Exercise | 7,118 | $34.40 | $244,895.00 | 22% 32.38K to 39.5K | |
| 04-Dec-17 4:14 PM View: | Haemonetics Corp. (HAE) | 01-Dec-17 | Market Option Sale | 7,118 | $57.06 | $406,184.00 | (18%) 39.5K to 32.38K | (54%) |
| 31-Jul-17 5:46 PM View: | Haemonetics Corp. (HAE) | 27-Jul-17 | Grant | 4,329 | $39.27 | $170,000.00 | 16% 27.33K to 31.66K | 124% |
| 23-Jul-15 12:43 PM View: | Haemonetics Corp. (HAE) | 21-Jul-15 | Grant | 4,337 | -- | -- | 25% 17.3K to 21.63K | |
| 24-Feb-15 9:13 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 21-Feb-15 | Disposition (change in control) | 30,413 | $46.00 | $1,399,000.00 | (100%) 30.41K to 0 | |
| 19-Feb-15 12:02 PM View: | Haemonetics Corp. (HAE) | 18-Feb-15 | Option Exercise | 11,328 | $29.23 | $331,117.00 | 65% 17.3K to 28.62K | |
| 19-Feb-15 12:02 PM View: | Haemonetics Corp. (HAE) | 18-Feb-15 | Market Option Sale | 11,328 | $43.45 | $492,161.00 | (40%) 28.62K to 17.3K | (103%) |
| 25-Jul-14 3:34 PM View: | Haemonetics Corp. (HAE) | 23-Jul-14 | Grant | 2,394 | -- | -- | 16% 14.9K to 17.3K | |
| 08-Jul-14 12:07 PM View: | Haemonetics Corp. (HAE) | 07-Jul-14 | Option Exercise | 5,837 | $18.10 | $105,642.00 | 39% 14.9K to 20.74K | |
| 08-Jul-14 12:07 PM View: | Haemonetics Corp. (HAE) | 07-Jul-14 | Market Option Sale (Planned) | 5,837 | $35.97 | $209,978.00 | (28%) 20.74K to 14.9K | (145%) |
| 10-Jun-14 1:05 PM View: | Haemonetics Corp. (HAE) | 06-Jun-14 | Option Exercise | 5,837 | $18.10 | $105,642.00 | 39% 14.9K to 20.74K | |
| 10-Jun-14 1:05 PM View: | Haemonetics Corp. (HAE) | 06-Jun-14 | Market Option Sale | 1,837 | $34.70 | $63,735.60 | (9%) 20.74K to 18.9K | (154%) |
| 10-Jun-14 1:05 PM View: | Haemonetics Corp. (HAE) | 06-Jun-14 | Market Option Sale (Planned) | 4,000 | $34.69 | $138,763.00 | (21%) 18.9K to 14.9K | (154%) |
| 08-May-14 4:25 PM View: | Haemonetics Corp. (HAE) | 07-May-14 | Option Exercise | 5,837 | $18.10 | $105,642.00 | 39% 14.9K to 20.74K | |
| 08-May-14 4:25 PM View: | Haemonetics Corp. (HAE) | 07-May-14 | Market Option Sale (Planned) | 5,837 | $31.14 | $181,780.00 | (28%) 20.74K to 14.9K | (183%) |
| 09-Apr-14 1:56 PM View: | Haemonetics Corp. (HAE) | 07-Apr-14 | Option Exercise | 5,837 | $18.10 | $105,642.00 | 39% 14.9K to 20.74K | |
| 09-Apr-14 1:56 PM View: | Haemonetics Corp. (HAE) | 07-Apr-14 | Market Option Sale (Planned) | 5,837 | $31.98 | $186,680.00 | (28%) 20.74K to 14.9K | (175%) |
| 12-Mar-14 5:06 PM View: | Haemonetics Corp. (HAE) | 10-Mar-14 | Option Exercise | 5,836 | $18.10 | $105,617.00 | 39% 14.9K to 20.74K | |
| 12-Mar-14 5:06 PM View: | Haemonetics Corp. (HAE) | 10-Mar-14 | Market Option Sale (Planned) | 5,836 | $36.70 | $214,184.00 | (28%) 20.74K to 14.9K | (140%) |
| 18-Feb-14 12:17 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-14 | Option Exercise | 15,188 | -- | -- | 100% 15.22K to 30.41K | |
| 07-Jan-14 3:23 PM View: | Dendreon Corp. (DNDN) | 03-Jan-14 | Grant | 25,000 | -- | -- | 40% 62.25K to 87.25K | |
| 26-Jul-13 6:03 PM View: | Haemonetics Corp. (HAE) | 24-Jul-13 | Grant | 1,649 | -- | -- | 12% 13.25K to 14.9K | |
| 11-Feb-13 4:42 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-13 | Acquisition (other) | 15,225 | -- | -- | 100% 0 to 15.22K | |
| 07-Jan-13 5:10 PM View: | Dendreon Corp. (DNDN) | 03-Jan-13 | Grant | 25,000 | -- | -- | 67% 37.25K to 62.25K | |
| 14-Nov-12 5:35 PM View: | Haemonetics Corp. (HAE) | 12-Nov-12 | Option Exercise | 16,000 | $38.47 | $615,510.00 | 241% 6.63K to 22.63K | |
| 14-Nov-12 5:35 PM View: | Haemonetics Corp. (HAE) | 12-Nov-12 | Market Option Sale | 16,000 | $80.40 | $1,286,340.00 | (71%) 22.63K to 6.63K | (9%) |
| 15-Aug-12 6:06 PM View: | Haemonetics Corp. (HAE) | 13-Aug-12 | Option Exercise | 6,000 | $44.74 | $268,440.00 | 91% 6.63K to 12.63K | |
| 15-Aug-12 6:06 PM View: | Haemonetics Corp. (HAE) | 13-Aug-12 | Market Option Sale | 6,000 | $70.05 | $420,310.00 | (48%) 12.63K to 6.63K | (24%) |
| 31-Jul-12 5:23 PM View: | Haemonetics Corp. (HAE) | 27-Jul-12 | Grant | 1,031 | $0.01 | $10.31 | 18% 5.59K to 6.63K | |
| 09-Feb-12 4:10 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-12 | Grant | 15,225 | -- | -- | 100% 0 to 15.22K | |
| 05-Jan-12 6:46 PM View: | Dendreon Corp. (DNDN) | 03-Jan-12 | Grant | 25,000 | -- | -- | 204% 12.25K to 37.25K | |
| 17-Aug-11 4:39 PM View: | Haemonetics Corp. (HAE) | 15-Aug-11 | Market Sale | 850 | $59.74 | $50,779.00 | (13%) 6.45K to 5.59K | (45%) |
| 24-Jan-11 8:55 PM View: | Dendreon Corp. (DNDN) | 20-Jan-11 | Grant | 3,507 | -- | -- | 40% 8.74K to 12.25K | |
| 08-Nov-10 4:21 PM View: | Haemonetics Corp. (HAE) | 05-Nov-10 | Market Sale | 6,000 | $57.72 | $346,300.00 | (52%) 11.5K to 5.5K | (52%) |
| 02-Aug-10 5:24 PM View: | Haemonetics Corp. (HAE) | 29-Jul-10 | Grant | 1,193 | $0.01 | $11.93 | 12% 10.31K to 11.5K | |
| 25-Jan-10 6:02 PM View: | Dendreon Corp. (DNDN) | 21-Jan-10 | Grant | 3,750 | -- | -- | 75% 4.99K to 8.74K | |
| 09-Oct-09 7:37 PM View: | Dendreon Corp. (DNDN) | 07-Oct-09 | Grant | 4,994 | -- | -- | 100% 0 to 4.99K | |
| 27-Aug-09 3:33 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 27-Aug-09 | Disposition | 9,120 | $16.50 | $150,480.00 | (100%) 9.12K to 0 | < 1% |
| 21-Aug-09 4:54 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 20-Aug-09 | Disposition (change in control) | 32,817 | $16.50 | $541,480.00 | (78%) 41.94K to 9.12K | < 1% |
| 03-Aug-09 2:46 PM View: | Haemonetics Corp. (HAE) | 30-Jul-09 | Grant | 367 | $0.01 | $3.67 | 4% 9.94K to 10.31K | |
| 27-May-09 4:57 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 22-May-09 | Grant | 12,160 | -- | -- | 41% 29.78K to 41.94K | |
| 06-Nov-08 6:04 PM View: | Haemonetics Corp. (HAE) | 05-Nov-08 | Market Purchase | 3,500 | $57.95 | $202,829.00 | 54% 6.44K to 9.94K | 52% |
| 04-Aug-08 6:32 PM View: | Haemonetics Corp. (HAE) | 31-Jul-08 | Grant | 354 | $0.01 | $3.54 | 6% 6.09K to 6.44K | 563600% |
| 09-Jun-08 5:03 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 05-Jun-08 | Grant | 10,121 | -- | -- | 51% 19.66K to 29.78K | |
| 03-Jun-08 11:01 AM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 02-Jun-08 | Market Purchase | 4,400 | $11.41 | $50,185.60 | 29% 15.26K to 19.66K | 47% |